The Effect of Minimally Invasive Surfactant Therapy on Diaphragmatic Activity

Neonatology. 2018;114(1):76-81. doi: 10.1159/000487916. Epub 2018 May 2.

Abstract

Background: Minimally invasive surfactant therapy (MIST) is increasingly used to treat preterm infants with respiratory distress syndrome (RDS). However, the effect of MIST on breathing effort is poorly studied.

Objectives: To describe the effect of MIST on neural breathing effort assessed with transcutaneous electromyography of the diaphragm (dEMG) in preterm infants with RDS.

Methods: Preterm infants with a gestational age < 37 weeks treated with MIST for RDS were included. dEMG measurements were done from 15 min before to 1 h after MIST. The percentage change in dEMG activity after MIST and the clinical response were analyzed.

Results: Twenty preterm infants (mean gestational age 29.3 [SD 2.1] weeks; mean birth weight 1,230 [SD 391] g) were included. Seventeen infants did complete the 1-h measurement. Eleven (65%) infants had a decrease in their peakdEMG activity (median change -11.8% [IQR -26.8 to 5.8, p = 0.08]) 1 h after MIST. TonicdEMG activity decreased in 12 (71%) infants, with a median reduction of 6.3% (IQR -29.2 to 9.0, p = 0.07). FiO2 showed a rapid decrease following MIST (before, 0.47 [IQR 0.38-0.84]; 1 h after, 0.25 [IQR 0.21-0.30], p < 0.001).

Conclusion: In addition to improved oxygenation, MIST results in a decrease in neural breathing effort measured by dEMG activity in the majority of preterm infants with RDS.

Keywords: Electromyography of the diaphragm; Preterm infants; Respiratory distress syndrome; Surfactant.

Publication types

  • Observational Study

MeSH terms

  • Birth Weight
  • Continuous Positive Airway Pressure
  • Diaphragm / physiology*
  • Electromyography
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Netherlands
  • Oxygen / metabolism
  • Oxygen Inhalation Therapy / methods*
  • Prospective Studies
  • Pulmonary Surfactants / administration & dosage*
  • Respiratory Distress Syndrome, Newborn / therapy*

Substances

  • Pulmonary Surfactants
  • Oxygen